Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Epidemiol Infect ; 150: e181, 2022 10 19.
Article in English | MEDLINE | ID: mdl-36384981

ABSTRACT

The Guillain-Barré syndrome (GBS) has been previously associated with Zika virus infection. We analysed the data from all the patients with GBS diagnosis that were admitted to a referral hospital, in Tapachula City during the period from January 2013 to August 2016, comparing the incidence of GBS according to the temporality of the Zika outbreak in Southern Mexico. Additionally, we described the clinical and epidemiological characteristics of the GBS patients admitted before or after the Zika outbreak. We observed a sharp increase in the number of patients hospitalised due to GBS from the time the first confirmed Zika cases appeared in Mexico. Clinically we observed GBS cases before zika outbreak had more frequently history of respiratory/gastrointestinal symptoms and GBS during zika outbreak had significantly more frequently recent history of rash/conjunctivitis. Although we cannot affirm that the increased cases of GBS have a specific aetiologic association with Zika, our results suggest that this observed outbreak of in Tapachula, might have been associated to the emerging Zika epidemic, locally and suggests that rare complications associated with acute infections (such as GBS) might be useful in the surveillance systems for emerging infections.


Subject(s)
Guillain-Barre Syndrome , Zika Virus Infection , Zika Virus , Humans , Mexico/epidemiology , Guillain-Barre Syndrome/epidemiology , Guillain-Barre Syndrome/complications , Zika Virus Infection/complications , Zika Virus Infection/epidemiology , Disease Outbreaks
2.
Int J Infect Dis ; 94: 4-11, 2020 May.
Article in English | MEDLINE | ID: mdl-32081772

ABSTRACT

OBJECTIVES: To describe the kinetics of circulating cytokines and chemokines in humans with ZIKAV infection. METHODS: Serum levels of different immune mediators in patients with ZIKAV infection were measured at distinct stages of the disease, as well as in culture supernatants from human monocytes infected with a clinical ZIKAV isolate. We also looked for clinical features associated with specific immune signatures among symptomatic patients. RESULTS: We evaluated 23 ZIKAV-infected patients. Their mean age was 32 ± 8.3 years and 65% were female. ZIKAV patients showed elevated IL-9, IL-17A, and CXCL10 levels at acute stages of the disease. At day 28, levels of CCL4 and CCL5 were increased, whereas IL-1RA, CXCL8 and CCL2 were decreased. At baseline, IL-7 was increased among patients with headache, whereas CCL2, and CCL3 were decreased in patients with bleeding and rash, respectively. Our clinical ZIKAV isolate induced a broad immune response in monocytes that did not resemble the signature observed in ZIKAV patients. CONCLUSIONS: We showed a unique immune signature in our cohort of ZIKAV-infected patients. Our study may provide valuable evidence helpful to identify immune correlates of protection against ZIKAV.


Subject(s)
Chemokines/blood , Cytokines/blood , Zika Virus Infection/immunology , Zika Virus/immunology , Adult , Cohort Studies , Female , Humans , Interleukin 1 Receptor Antagonist Protein/blood , Interleukin-8/blood , Male , Mexico , Zika Virus Infection/blood , Zika Virus Infection/virology
3.
Nat Commun ; 10(1): 1943, 2019 04 26.
Article in English | MEDLINE | ID: mdl-31028263

ABSTRACT

Zika virus (ZIKV) outbreak in Americas led to extensive efforts to develop vaccines and ZIKV-specific diagnostics. In the current study, we use whole genome phage display library spanning the entire ZIKV genome (ZIKV-GFPDL) for in-depth immune profiling of IgG and IgM antibody repertoires in serum and urine longitudinal samples from individuals acutely infected with ZIKV. We observe a very diverse IgM immune repertoire encompassing the entire ZIKV polyprotein on day 0 in both serum and urine. ZIKV-specific IgG antibodies increase 10-fold between day 0 and day 7 in serum, but not in urine; these are highly focused on prM/E, NS1 and NS2B. Differential antibody affinity maturation is observed against ZIKV structural E protein compared with nonstructural protein NS1. Serum antibody affinity to ZIKV-E protein inversely correlates with ZIKV disease symptoms. Our study provides insight into unlinked evolution of immune response to ZIKV infection and identified unique targets for ZIKV serodiagnostics.


Subject(s)
Antibodies, Viral/blood , Zika Virus Infection/immunology , Antibodies, Viral/immunology , Antibody Affinity/physiology , Enzyme-Linked Immunosorbent Assay , Humans , Immunoglobulin G/blood , Viral Nonstructural Proteins/metabolism , Viral Vaccines/immunology , Zika Virus/immunology , Zika Virus Infection/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...